Funding News Edition: February 17, 2021 See more articles in this edition
Thinking about applying for a grant? The due date may not be the only date you need to know. You might also have deadlines for special requirements as many as 12 weeks before your due date.
Big grants, investigator-initiated clinical trials (IICTs), investigator-initiated program project (P01) grants, investigator-initiated resource-related research projects (R24), and conference grants/cooperative agreements (R13/U13) either require NIAID’s prior approval or prompt you to contact a program officer for prior consultation far in advance of your application due date.
Don’t miss out on the chance to submit your application for your desired due date because you didn’t contact NIAID early enough to obtain the prior approval letter needed for your application’s Cover Letter Attachment or you missed our advice on how to meet these grants’ requirements!
Big Grants
You must get NIAID’s approval for Big Grants—that is, grant application requests of $500,000 or more in direct costs for any one year. You need to request this approval a minimum of six weeks before you submit, but we recommend you contact your program officer as soon as you know your budget is likely to exceed this threshold. Learn more at Big Grants SOP.
This requirement does not apply to applications in response to requests for applications (RFAs) or any funding opportunity announcements (FOAs) that specify a budget limit. In those instances, follow the directions in the FOA.
Investigator-Initiated Clinical Trials
If you plan on applying for an IICT, whether through NIAID Clinical Trial Implementation Cooperative Agreement (U01, Clinical Trial Required), NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44, Clinical Trial Required), or NIH Research Project Grant (Parent R01, Clinical Trial Required), NIAID recommends that you begin consulting with your program officer at least 10 weeks before the application due date. For the Investigator-Initiated Extended Clinical Trial (R01, Clinical Trial Required) you should begin even earlier—touch base with staff 12 weeks before applying. See Prior Consultation Timeframes for Investigator-Initiated Clinical Trial Applications.
This allows us to help you optimize your application idea, ensure you meet any unique programmatic requirements, explain additional considerations for setting your milestones and budget, and advise you to apply for the right activity code. If you don’t speak with us first, you might not propose a sufficient budget to address our requirements or may not factor in considerations that could prevent you from completing the trial within your proposed project period. Even with a highly meritorious score, NIAID may not be able to make an award if your proposed trial is not an NIAID priority or is not feasible.
And remember that if you are requesting a big grant for your clinical trial, you need to get our prior approval; we recommend you do so during the prior consultation process.
Multiproject Research
We strongly encourage you to complete a consultation with NIAID program division staff if you're planning to submit an investigator-initiated P01 application (new, resubmission, or renewal). Do so at least 12 weeks before the application due date. The program officer will verify that a multiproject approach is suitable to your research.
Additionally, the program officer can provide input as to whether NIAID might be interested in funding the research areas or whether any division-specific requirements might apply to your project. Learning this information early and working with the program officer helps you avoid wasting time on an approach that NIAID is not interested in funding.
Note that the big grants policy applies to multiproject grants if you will request $500,000 or more in direct costs for any year of the overall program, even if none of the individual project requests will exceed $500,000. The deadline to request approval is six weeks or more before the application deadline, though we recommend you do so when completing the recommended prior consultation with NIAID staff 12 weeks before applying.
Conference and Resource Grants
Refer to our Conference Awards SOP if you plan to apply for an NIH Support for Conferences and Scientific Meetings (Parent R13) grant. Note that you’ll need to contact NIAID at least six weeks before you submit your application.
Because it is difficult to assess whether a given resource meets NIAID’s criteria for an NIAID Resource-Related Research Projects (R24) grant, we strongly encourage you to consult with NIAID staff 10 weeks before the application due date.
General Rules for All Applications
Make sure you are registered in eRA Commons and able to log in.
Submit your application sufficiently in advance of a given due date to allow yourself time to detect and resolve technical errors. We described such snafus, and how to avoid them, in our October 16, 2019 article “Apply Early To Guard Against Electronic Submission Errors.”
Letter of Intent
Although a Letter of Intent is often not required, is not binding, and does not factor into the review of a subsequent application, the information that it contains allows NIAID staff to estimate the potential review workload and plan the review. This helps ensure effective and efficient review of your application.
In your letter of intent, include the following information:
- Number and title of the funding opportunity
- Descriptive title of proposed research
- Name, address, and telephone number of the program director(s)/principal investigator(s)
- Names of other key personnel
- Participating institutions
Send the letter of intent to the contact listed in the FOA (generally staff in NIAID’s Scientific Review Program if the peer review will be conducted at NIAID).
While your letter of intent is due only 30 days before you submit your application, we advise you to reach out to the FOA’s scientific/research contact at least 10 to 12 weeks before applying. This will ensure that you meet all preapplication deadlines (such as the deadline for submitting a big grant), as well as help NIAID identify any issues that may cause your application to be withdrawn, not fare well in peer review, or have lowered potential for an award. Furthermore, the earlier you contact us, the earlier we can provide advice that you can use to improve your application.
Share the following information with the scientific/research contact listed in the FOA or your program officer so we can help you strengthen your application:
What To Discuss/Include | What We May Spot for You |
---|---|
Concise description of your proposed project. Do not send your entire application. |
|
Whether your plans touch on special policy areas, such as human subjects, clinical, or animal research. |
|
Name of pathogens you plan to study, if any. |
|
Whether the application is foreign or has foreign components. |
|
For more information on how NIAID staff can help you, see Contacting Program Officers and Grants Management Specialists.